{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:50:48Z","timestamp":1779335448315,"version":"3.51.4"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To compare the complications and oncological outcomes between video\u2010endoscopic inguinal lymph node dissection (\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      ) and open\n                      <jats:styled-content style=\"fixed-case\">ILND<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OILND<\/jats:styled-content>\n                      ) in men with carcinoma of the penis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>\n                      A prospectively collected institutional database was used to determine the outcomes in 42 consecutive patients undergoing\n                      <jats:styled-content style=\"fixed-case\">ILND<\/jats:styled-content>\n                      between 2008 and 2015 in a centre for treating penile cancer. Before 2013 all procedures were\n                      <jats:styled-content style=\"fixed-case\">OILND<\/jats:styled-content>\n                      s. Since 2013 we have performed\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      on all patients in need of\n                      <jats:styled-content style=\"fixed-case\">ILND<\/jats:styled-content>\n                      . The wound\u2010related and non\u2010wound\u2010related complications, length of stay, and oncological safety between\n                      <jats:styled-content style=\"fixed-case\">OILND<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      groups were compared. The mean duration of follow\u2010up was 71\u00a0months for\n                      <jats:styled-content style=\"fixed-case\">OILND<\/jats:styled-content>\n                      and 16\u00a0months for the\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the study period 42 patients underwent 68\n                      <jats:styled-content style=\"fixed-case\">ILND<\/jats:styled-content>\n                      s (\n                      <jats:styled-content style=\"fixed-case\">OILND<\/jats:styled-content>\n                      35,\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      33). The patients\u2019 demographics, primary stage and grade, and indications were comparable in both groups. There were no intraoperative complications in either group. The wound complication rate was significantly lower in the\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      group at 6% compared to 68% in the\n                      <jats:styled-content style=\"fixed-case\">OILND<\/jats:styled-content>\n                      group. Lymphocoele rates were similar in both the groups (27% and 20%). The\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      group had a better or the same lymph node yield, mean number of positive lymph nodes, and lymph node density confirming oncological safety. There were no groin recurrences in either group of patients.\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      significantly reduced the mean length of stay by 4.8\u00a0days (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">VEILND<\/jats:styled-content>\n                      is an oncologically safe procedure with considerably low morbidity and reduced length of stay, at a mean (range) follow\u2010up of 16 (4\u201335) months.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.13660","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T10:42:43Z","timestamp":1473936163000},"page":"530-534","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Prospective study comparing video\u2010endoscopic radical inguinal lymph node dissection (\n                    <scp>VEILND<\/scp>\n                    ) with open radical\n                    <scp>ILND<\/scp>\n                    (\n                    <scp>OILND<\/scp>\n                    ) for penile cancer over an 8\u2010year period"],"prefix":"10.1111","volume":"119","author":[{"given":"Vivekanandan","family":"Kumar","sequence":"first","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Krishna","family":"Sethia","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000048971.52053.8a"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.06.016"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1490-5"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-014-0412-7"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2007.0386"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.03.002"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64835-5"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13127"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.10.017"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65169-5"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1993.tb16304.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000131453.52463.8f"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.06.085"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.12.003"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318194d38f"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24295"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.06.038"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000132239.28989.e1"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2012.0489"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2014.10.062"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2014.01.019"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-003-2738-5"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.02.021"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13660","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13660","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.13660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:06:11Z","timestamp":1761735971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.13660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/bju.13660"],"URL":"https:\/\/doi.org\/10.1111\/bju.13660","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726740287.793558989","asserted-by":"object"}]},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]},"assertion":[{"value":"2016-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}